Favorable Effects of Inhaled Treprostinil in Severe Pulmonary Hypertension
- 26 September 2006
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 48 (8) , 1672-1681
- https://doi.org/10.1016/j.jacc.2006.06.062
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Inhaled Treprostinil for Treatment of Chronic Pulmonary Arterial HypertensionAnnals of Internal Medicine, 2006
- Transition from Intravenous Epoprostenol to Intravenous Treprostinil in Pulmonary HypertensionAmerican Journal of Respiratory and Critical Care Medicine, 2005
- Treprostinil, a Prostacyclin Analogue, in Pulmonary Arterial Hypertension Associated With Connective Tissue DiseaseChest, 2004
- Prostanoid therapy for pulmonary arterial hypertensionJournal of the American College of Cardiology, 2004
- Pulmonary arterial hypertension: a look to the futureJournal of the American College of Cardiology, 2004
- Prostacyclin and its analogues in the treatment of pulmonary hypertensionPharmacology & Therapeutics, 2004
- Absolute Bioavailability and Pharmacokinetics of Treprostinil Sodium Administered by Acute Subcutaneous InfusionThe Journal of Clinical Pharmacology, 2004
- Pharmacodynamics and Pharmacokinetics of Inhaled Iloprost, Aerosolized by Three Different Devices, in Severe Pulmonary HypertensionChest, 2003
- Inhaled Iloprost for Severe Pulmonary HypertensionNew England Journal of Medicine, 2002
- Continuous Subcutaneous Infusion of Treprostinil, a Prostacyclin Analogue, in Patients with Pulmonary Arterial HypertensionAmerican Journal of Respiratory and Critical Care Medicine, 2002